BioASP portal provides Dutch researchers with access to Rosetta Resolver Software in National Genomics Initiative
Stichting Netherlands Bioinformatics Centre (NBIC), Rosetta Biosoftware and Agilent Technologies have announced an agreement to make the Rosetta Resolver system available to the Dutch research community.
The Stichting NBIC has obtained a license to the Rosetta Resolver system in which access will be made available through NBIC's BioASP portal to a larger group of Dutch researchers.
BioASP maintains a unique Application Service Provider (ASP) model for a wide group of researchers in the Netherlands and will provide the required infrastructure, support and expertise to users in at least ten academic research labs, with this number expected to grow.
The Rosetta Resolver system is an enterprise-wide gene expression data analysis system that is developed by Rosetta Biosoftware and distributed exclusively by Agilent.
Researchers use gene expression technologies to measure cellular gene activity under different conditions, with the goal of understanding the molecular basis of disease and discovering new treatments.
High-quality analytical software is critical for the interpretation of gene expression data.
The BioASP (Bioinformatics Applications Service Provider) portal is an integral part of the strategy outlined by the National Genomics Initiative, a cabinet-appointed task force established in the Netherlands in late 2001.
By combining the opportunities offered by genomics research with the scientific knowledge and expertise of the Netherlands, the task force aims to develop a national genomics infrastructure of world caliber within five years. "The agreement with Rosetta and Agilent allows institutions participating in BioASPsp to access the Rosetta Resolver software at a considerably reduced cost of ownership by leveraging BioASP's server and portal service", said Jan Willem Tellegen, managing director of BioASP.
"Researchers will enjoy considerable gains in efficiency because of the highly scalable infrastructure.
We are very excited about the opportunity to provide leading researchers throughout the Netherlands access to the Rosetta Resolver system.
We expect that cooperation between researchers will be greatly enhanced, because of improved data exchange possibilities and easier access to databases." "We are proud to have Rosetta Resolver selected by BioASP to serve as the central pillar for gene expression analysis for researchers within the Netherlands." said Douglas Bassett, vice president and general manager of Rosetta Biosoftware.
"We are excited to work collaboratively with BioASP as it continues to expand a cutting-edge national infrastructure for genomics research." "The work being done by BioASP and the government of the Netherlands provides a model for other nations and academic organisations that are uniting together to build genomics research programs," said Barney Saunders, general manager and vice president of Agilent's BioResearch Solutions unit.
As the service is implemented, other tools will be integrated ranging from professional storage services to integration of other gene expression tools, already available through BioASP.
New participants are expected to join the microarray services user group in the course of this year, including participants from the private sector.
